Ghent University Academic Bibliography

Show Sort by

Your filters: cql: jcr.category exact "IMMUNOLOGY"

Add to list
Phase 1 study of AMG 160, a half-life extended BITE (R) (bispecific T-cell engager) therapy targeting prostate-specific membrane antigen, in patients with metastatic castration-resistant prostate cancer

Tanya Dorff, Matthew Rettig, Jean-Pascal Machiels, Martijn Lolkema, Karen Autio, Richard Greil, Sylvie Rottey (UGent) , Nabil Adra, Mark Salvati, Shirley Poon, et al.

(2020) JOURNAL FOR IMMUNOTHERAPY OF CANCER. 8(Supplement: 3). p.A207-A208
Add to list
- Journal Article
- A1
- open access
An anti-siglec-8 antibody depletes sputum eosinophils from asthmatic subjects and inhibits lung mast cells

Sheena C. Kerr, Jeanmarie R. Gonzalez, Julia Schanin, Michael C. Peters, Bart Lambrecht (UGent) , Emily C. Brock, Annabelle Charbit, K. Mark Ansel, Bradford A. Youngblood and John V. Fahy

(2020) CLINICAL AND EXPERIMENTAL ALLERGY. 50(8). p.904-914
Add to list
- Journal Article
- A1
- open access
Managing granulomatous-lymphocytic interstitial lung disease in common variable immunodeficiency disorders : e-GLILDnet International Clinicians Survey

Annick A. J. M. van de Ven, Tiago M. Alfaro, Alexandra Robinson, Ulrich Baumann, Anne Bergeron, Siobhan O. Burns, Alison M. Condliffe, Borre Fevang, Andrew R. Gennery, Filomeen Haerynck (UGent) , et al.

(2020) FRONTIERS IN IMMUNOLOGY. 11.
Add to list
- Journal Article
- A1
- open access
Familial mediterranean fever and COVID-19 : friends or foes?

Alessandro Stella, Mohamed Lamkanfi (UGent) and Piero Portincasa

(2020) FRONTIERS IN IMMUNOLOGY. 11.
Add to list
- Journal Article
- A1
- open access
Therapeutic modulation of inflammasome pathways

Dhruv Chauhan, Lieselotte Vande Walle (UGent) and Mohamed Lamkanfi (UGent)

(2020) IMMUNOLOGICAL REVIEWS. 297(1). p.123-138
Add to list
- Miscellaneous
Snapshot of a deadly embrace : the caspase-1-GSDMD interface

Lieselotte Vande Walle (UGent) and Mohamed Lamkanfi (UGent)

(2020) IMMUNITY. 53(1). p.6-8
Add to list
- Journal Article
- A1
- open access
Modulation of signaling mediated by TSLP and IL-7 in inflammation, autoimmune diseases, and cancer

Iva Marković (UGent) and Savvas Savvides (UGent)

(2020) FRONTIERS IN IMMUNOLOGY. 11.
Add to list
- Journal Article
- A1
- open access
Glucocorticoids in sepsis : to be or not to be

Jolien Vandewalle (UGent) and Claude Libert (UGent)

(2020) FRONTIERS IN IMMUNOLOGY. 11.
Add to list
- Journal Article
- A1
- open access
Single-chain soluble receptor fusion proteins as versatile cytokine inhibitors

Aurora Holgado Muñoz (UGent) , Harald Braun (UGent) , Kenneth Verstraete (UGent) , Domien Vanneste, Nico Callewaert (UGent) , Savvas Savvides (UGent) , Inna Afonina (UGent) and Rudi Beyaert (UGent)

(2020) FRONTIERS IN IMMUNOLOGY. 11.
Add to list
- Journal Article
- A1
- open access
Neurocognitive function, psychosocial outcome, and health-related quality of life of the first-generation metastatic melanoma survivors treated with Ipilimumab

Anne Rogiers, Christophe Leys, Justine Lauwyck, Adrian Schembri, Gil Awada, Julia Katharina Schwarze, Jennifer De Cremer, Peter Theuns, Paul Maruff, Mark De Ridder, et al.

(2020) JOURNAL OF IMMUNOLOGY RESEARCH. 2020.

Academic Bibliography

Phase 1 study of AMG 160, a half-life extended BITE (R) (bispecific T-cell engager) therapy targeting prostate-specific membrane antigen, in patients with metastatic castration-resistant prostate cancer

An anti-siglec-8 antibody depletes sputum eosinophils from asthmatic subjects and inhibits lung mast cells

Managing granulomatous-lymphocytic interstitial lung disease in common variable immunodeficiency disorders : e-GLILDnet International Clinicians Survey

Familial mediterranean fever and COVID-19 : friends or foes?

Therapeutic modulation of inflammasome pathways

Snapshot of a deadly embrace : the caspase-1-GSDMD interface

Modulation of signaling mediated by TSLP and IL-7 in inflammation, autoimmune diseases, and cancer

Glucocorticoids in sepsis : to be or not to be

Single-chain soluble receptor fusion proteins as versatile cytokine inhibitors

Neurocognitive function, psychosocial outcome, and health-related quality of life of the first-generation metastatic melanoma survivors treated with Ipilimumab

Contents

Support

Contact